Form 4 Tracker
Helen Louise Collins

CHIEF MEDICAL OFFICER; Director · 10 filings · Latest: Jul 17, 2026

Enliven Therapeutics, Inc.
Kura Oncology, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERJul 17, 2026
Sale
$52.675,000$263.4K25,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERJul 17, 2026
Option Exercise
$2.485,000$12.4K30,000
ELVN
Collins Helen LouiseJul 17, 2026
Proposed Sale
$50.8615,000$762.9K
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERJun 17, 2026
Sale
$43.805,000$219.0K25,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERJun 17, 2026
Option Exercise
$2.485,000$12.4K30,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMay 18, 2026
Sale
$39.795,000$199.0K25,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMay 18, 2026
Option Exercise
$2.485,000$12.4K30,000
ELVN
Collins Helen LouiseMay 18, 2026
Proposed Sale
$41.3415,000$620.1K
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERApr 17, 2026
Sale
$47.675,000$238.4K25,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERApr 17, 2026
Option Exercise
$2.485,000$12.4K30,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMar 25, 2026
Sale
$35.1040,000$1.4M25,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMar 25, 2026
Option Exercise
$2.4840,000$99.2K65,000
ELVN
Collins Helen LouiseMar 25, 2026
Proposed Sale
$31.1545,000$1.4M
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMar 17, 2026
Sale
$27.765,000$138.8K25,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMar 17, 2026
Option Exercise
$2.485,000$12.4K30,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMar 10, 2026
Sale
$30.1910,129$305.8K25,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMar 10, 2026
Option Exercise
$2.4810,129$25.1K35,129
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMar 9, 2026
Sale
$30.0229,871$896.8K25,000
ELVN
Helen Louise CollinsCHIEF MEDICAL OFFICERMar 9, 2026
Option Exercise
$2.4829,871$74.1K54,871
ELVN
Collins Helen LouiseMar 9, 2026
Proposed Sale
$29.4445,000$1.3M

Page 1 of 2

Next →